Accuracy Coverage Pricing Contact
Biogen Idec Inc

Biogen Idec Inc (BIIB)

In November 2003, Biogen and IDEC Pharmaceuticals finalised their $6bn merger, creating Biogen Idec, the third-largest biotechnology company in the world. The company is now a global leader in the development, manufacturing, and commercialisation of novel therapies. Its major products include treatments for relapsing multiple sclerosis, certain B-cell non-Hodgkin's lymphomas and adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.

From their web site: "Biogen Idec does not pay a dividend..."

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0c
2007 0.0c 0%
2008 0.0c 0%
2009 0.0c 0%

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount

Biogen Idec Inc optimized dividend - 12 month history

Optimized dividend graph demo

Biogen Idec Inc share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial